Regnology upgrades Ascend platform with agentic AI layer, targeting autonomous regulatory reporting for banks and supervisors
AviadoBio opens fourth ASPIRE-FTD cohort as AVB-101 regains full development rights and secures fresh backing from leading dementia foundations
NTPC Green Energy (NTPCGREEN) locks in India’s first large-scale green ammonia supply deal under SIGHT
Optiscan Imaging (ASX: OIL) files FDA dossier for InSpecta veterinary device, targeting an $11.9bn market
Read More Pharma Industry News Is Johnson & Johnson quietly building a new autoimmune franchise around FcRn inhibition? Johnson & Johnson is expanding nipocalimab into multiple autoimmune indications. Find out if FcRn inhibition is the foundation of its next blockbuster franchise. bySrinathOctober 30, 2025